Publication, Part of Health and Care of People with Learning Disabilities
Health and Care of People with Learning Disabilities Experimental Statistics 2020 to 2021
Experimental statistics, Other reports and statistics, Official statistics in development
Epilepsy and ADHD
Epilepsy and on drug treatment for epilepsy
The percentage of patients with a learning disability, who have a diagnosis of epilepsy and are currently prescribed epilepsy drugs is significantly greater than the percentage of patients without a learning disability, who have a diagnosis of epilepsy and are currently prescribed epilepsy drugs for each year between 2016-17 and 2020-21. Although the percentage of patients with a learning disability, who have a diagnosis of epilepsy and are currently prescribed epilepsy drugs has fallen steadily between 2016-17 (17.2%) and 2020-21 (16.6%), this has remained stable at 0.6% in those without a learning disability, who have a diagnosis of epilepsy and are currently prescribed epilepsy drugs.
ADHD
The percentage of patients with a learning disability, who also have a diagnosis of ADHD is significantly greater than the percentage of the population who have a diagnosis of ADHD but do not have a learning disability. The percentage of patients with a learning disability, who also have a diagnosis of ADHD has risen steadily between 2016-17 (5.1%) and 2020-21 (7.4%), whilst those without a learning disability, who have a diagnosis of ADHD rose by 0.2 percentage points (0.5% to 0.7%).
ADHD with melatonin
Each year between 2016-17 and 2020-21, a significantly larger percentage of patients with a learning disability, who also have a diagnosis of ADHD, and are currently treated with melatonin than the population of patients who have a diagnosis of ADHD and are currently treated with melatonin who don’t have a learning disability.
The percentage of patients with a learning disability, who have also been diagnosed with ADHD and are currently treated with melatonin rose by 1.5 percentage points between 2019-20 (12.5%) and 2020-21 (14.0%); this is over double the percentage point change compared to previous years. The percentage of patients without a learning disability, who also have a diagnosis of ADHD and are currently treated with melatonin has risen by 0.1 percentage points between 2019-20 (8.3%) and 2020-21 (8.4%).
Last edited: 9 March 2023 1:59 pm